Page last updated: 2024-08-22

camptothecin and cbp-93872

camptothecin has been researched along with cbp-93872 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aoki, Y; Harada, N; Makishima, F; Nakanishi, K; Nakanishi, M; Sakumoto, H; Tsuchiya, M; Watanabe, Y; Yoshimura, Y	1

Other Studies

1 other study(ies) available for camptothecin and cbp-93872

Article	Year
Identification of a checkpoint modulator with synthetic lethality to p53 mutants. Anti-cancer drugs, 2011, Volume: 22, Issue:10 Topics: Aniline Compounds; Antineoplastic Agents; Camptothecin; CDC2 Protein Kinase; Cell Proliferation; Checkpoint Kinase 1; Cyclin B; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; G1 Phase; G2 Phase; High-Throughput Screening Assays; HT29 Cells; Humans; Mutation; Phosphorylation; Propanolamines; Protein Kinases; Reproducibility of Results; Tumor Suppressor Protein p53	2011

Article

Year

Identification of a checkpoint modulator with synthetic lethality to p53 mutants.

Anti-cancer drugs, 2011, Volume: 22, Issue:10

Topics: Aniline Compounds; Antineoplastic Agents; Camptothecin; CDC2 Protein Kinase; Cell Proliferation; Checkpoint Kinase 1; Cyclin B; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; G1 Phase; G2 Phase; High-Throughput Screening Assays; HT29 Cells; Humans; Mutation; Phosphorylation; Propanolamines; Protein Kinases; Reproducibility of Results; Tumor Suppressor Protein p53

2011